Arash Zarei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arash Zarei has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amir Arsalan Ghahari
Department of Mycobacteriology and Pulmonary Research Pasteur Institute of Iran Tehran Iran
1 shared publication - Aseel Smerat
Faculty of Educational Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan
1 shared publication - Fatemeh Malekinejad
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Kianoush Saberi
Department of Anesthesiology, Medical Faculty, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Makhmudjon Muxamedovich Abdullayev
Department of Mechatronics and Robotics, Faculty of Electronics and Automation Tashkent State Technical University Named After Islam Karimov Tashkent Uzbekistan
1 shared publication - Maksudova Malika Khamdamjonovna
Department of Faculty and Hospital Therapy No. 2, Nephrology and Hemodialysis Tashkent State Medical University Tashkent Uzbekistan
1 shared publication
Latest Publications
- Open Access
- 10 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5)
Artificial Intelligence in Veterinary Neurology: Comparative Insights From Human Medicine and Cross‐Species Technology Transfer
Background: Artificial intelligence (AI) is increasingly explored in veterinary neurology for pattern recognition, prediction and clinical decision support, with relevance to comparative and translational neuroscience. Objectives: This review examines AI applications in veterinary neurology, compares them with human neurology and evaluates cross‐species technology transfer within a One Health framework. Methods: A narrative review synthesized evidence across AI domains in veterinary neurology, including neuroimaging and radiomics, electrophysiology and seizure detection or forecasting, gait and pain assessment, morphometric biomarker discovery, prognostic modelling and laboratory diagnostic tools. Human studies were considered to identify translational opportunities, methodological challenges and the value of transfer learning and domain adaptation. Results: Available evidence suggests that AI holds promise for pattern recognition, prediction and decision support in veterinary neurology. Reported applications include canine brain tumour classification, spinal lesion grading, seizure monitoring and quantitative gait analysis, with encouraging performance. However, most applications remain proof‐of‐concept. The evidence base is dominated by retrospective single‐centre studies with small samples, heterogeneous protocols and limited prospective or external validation. Model calibration, uncertainty reporting and clinically relevant error trade‐offs are often insufficiently addressed. Transfer learning and domain adaptation may help overcome limited veterinary datasets, while naturally occurring neurological disease in dogs may also support refinement of human AI systems. Conclusions: AI in veterinary neurology is a promising but early field. Future progress will require multi‐centre collaboration, standardized data practices, explainable and ethically governed models and stronger One Health partnerships to support safe translation.
- 10 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5)
Open AccessArtificial Intelligence in Veterinary Neurology: Comparative Insights From Human Medicine and Cross‐Species Technology Transfer
Background: Artificial intelligence (AI) is increasingly explored in veterinary neurology for pattern recognition, prediction and clinical decision support, with relevance to comparative and translational neuroscience. Objectives: This review examines AI applications in veterinary neurology, compares them with human neurology and evaluates cross‐species technology transfer within a One Health framework. Methods: A narrative review synthesized evidence across AI domains in veterinary neurology, including neuroimaging and radiomics, electrophysiology and seizure detection or forecasting, gait and pain assessment, morphometric biomarker discovery, prognostic modelling and laboratory diagnostic tools. Human studies were considered to identify translational opportunities, methodological challenges and the value of transfer learning and domain adaptation. Results: Available evidence suggests that AI holds promise for pattern recognition, prediction and decision support in veterinary neurology. Reported applications include canine brain tumour classification, spinal lesion grading, seizure monitoring and quantitative gait analysis, with encouraging performance. However, most applications remain proof‐of‐concept. The evidence base is dominated by retrospective single‐centre studies with small samples, heterogeneous protocols and limited prospective or external validation. Model calibration, uncertainty reporting and clinically relevant error trade‐offs are often insufficiently addressed. Transfer learning and domain adaptation may help overcome limited veterinary datasets, while naturally occurring neurological disease in dogs may also support refinement of human AI systems. Conclusions: AI in veterinary neurology is a promising but early field. Future progress will require multi‐centre collaboration, standardized data practices, explainable and ethically governed models and stronger One Health partnerships to support safe translation.